- Home
- PLX vs MGF Comparison
PLX vs MGF Comparison
Compare PLX & MGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- MGF
- Stock Information
- Founded
- PLX 1993
- MGF 1987
- Country
- PLX United States
- MGF United States
- Employees
- PLX N/A
- MGF N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- MGF Trusts Except Educational Religious and Charitable
- Sector
- PLX Health Care
- MGF Finance
- Exchange
- PLX Nasdaq
- MGF Nasdaq
- Market Cap
- PLX 122.6M
- MGF 100.1M
- IPO Year
- PLX 1998
- MGF N/A
- Fundamental
- Price
- PLX $1.37
- MGF $3.05
- Analyst Decision
- PLX Strong Buy
- MGF
- Analyst Count
- PLX 1
- MGF 0
- Target Price
- PLX $15.00
- MGF N/A
- AVG Volume (30 Days)
- PLX 1.3M
- MGF 104.4K
- Earning Date
- PLX 08-13-2025
- MGF 01-01-0001
- Dividend Yield
- PLX N/A
- MGF 7.64%
- EPS Growth
- PLX N/A
- MGF N/A
- EPS
- PLX 0.05
- MGF N/A
- Revenue
- PLX $59,764,000.00
- MGF N/A
- Revenue This Year
- PLX $65.02
- MGF N/A
- Revenue Next Year
- PLX $57.34
- MGF N/A
- P/E Ratio
- PLX $28.34
- MGF N/A
- Revenue Growth
- PLX 0.18
- MGF N/A
- 52 Week Low
- PLX $0.82
- MGF $2.91
- 52 Week High
- PLX $3.10
- MGF $3.46
- Technical
- Relative Strength Index (RSI)
- PLX 41.78
- MGF 42.82
- Support Level
- PLX $1.43
- MGF $3.07
- Resistance Level
- PLX $1.54
- MGF $3.12
- Average True Range (ATR)
- PLX 0.09
- MGF 0.03
- MACD
- PLX 0.01
- MGF -0.00
- Stochastic Oscillator
- PLX 5.77
- MGF 22.22
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About MGF MFS Government Markets Income Trust
MFS Government Markets Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income. The fund invests a majority of the net assets, including borrowings for investment purposes, in U.S. and foreign government securities. The company invest various sectors like U.S. Treasury Securities, Mortgage-Backed Securities, Investment Grade Corporates, Municipal Bonds, Non-U.S. Government Bonds, etc, out of which maximum revenue is gained from U.S. Treasury Securities.